Skip to main content
SpringerLink
Log in

The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The GHRH test may represent a new tool in the study of GH dynamics in acromegaly. GH responsiveness to GHRH 1–40 (50 µg iv) has been studied in 21 acromegalic patients. Nineteen out of 21 had active disease. Five patients were also studied 1–12 months after neurosurgery. Two apparently cured acromegalics were studied 1–2 yr after surgery. GH secretion has been evaluated in all patients by means of TRH, bromocriptine and insulin hypoglycemia tests, too. GH response to GHRH has also been performed in 14 normal subjects. In acromegaly, GH responses after GHRH (p < 0.01 vs placebo) were variable. The GH peak ranged from 8 to 445 ng/ml in patients with active disease. Maximum GH increase after GHRH (calculated as peak/basal value ratio) was significantly reduced in acromegaly (2.9 ± 0.5 ng/ml; mean ± SE) in comparison to controls (34.1 ± 10.9 ng/ml; p < 0.01). No significant differences in GH pattern after GHRH were found between untreated and previously treated patients with active disease. A significant correlation was found between GH basal levels and GH incremental area (p < 0.05) and between GH basal and peak levels (p < 0.01) after GHRH. A signifcant increase in PRL secretion was observed in acromegalic patients after GHRH (p < 0.01 vs placebo). No discernable variation was found in the other pituitary hormones pattern after the peptide administration. A positive correlation was observed between GH increase after GHRH and insulin hypoglycemia (p < 0.01). After surgery, GH increase after GHRH got up to the normal range only in cured patients. GH increase in these patients was significantly inversely correlated with Sm-C levels (p < 0.01). The phenomenon of a normal GH responsiveness to GHRH could be regarded as additional evidence of successful surgical therapy in acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liuzzi A., Chiodini P.G., Botalla L., Cremascoli G., Silvestrini F. Inhibitory effect of L-Dopa on GH release in acromegalic patients. J. Clin. Endocrinol. Metab. 35: 941, 1972.

    Article  PubMed  CAS  Google Scholar 

  2. Liuzzi A., Chiodini P.G., Botalla L., Silvestrini F., Müller E.E. Growth hormone releasing activity of TRH and GH lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses. J. Clin. Endocrinol. Metab. 39: 871, 1974.

    Article  PubMed  CAS  Google Scholar 

  3. Faglia G., Beck-Peccoz P., Ferrari C., Travaglini P., Ambrosi B., Spada A. Plasma growth hormone response to thyrotropin-releasing hormone in patients with acromegaly. J. Clin. Endocrinol. Metab. 36: 1259, 1973.

    Article  PubMed  CAS  Google Scholar 

  4. Faglia G., Beck-Peccoz P., Travaglini P., Paracchi A., Spada A., Lewin A. Elevations in plasma growth hormone concentration after luteinizing hormone releasing hormone (LHRH) in patients with active acromegaly. J. Clin. Endocrinol. Metab. 37: 338, 1973.

    Article  PubMed  CAS  Google Scholar 

  5. Giordano G., Marugo M., Minuto F., Barreca T. Meccanismi ipotalamici nella patogenesi dell’acromegalia. Folia Endocrinol. 27: 1, 1974.

    PubMed  CAS  Google Scholar 

  6. Hanew K., Kokubun M., Sasaki A., Mouri T., Yoshinoga K. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly. J. Clin. Endocrinol. Metab. 51: 292, 1980.

    Article  PubMed  CAS  Google Scholar 

  7. Lawrence A.M., Goldfine I.D., Kirsteins L Growth hormone dynamics in acromegaly. J. Clin. Endocrinol. Metab. 31: 239, 1970.

    Article  PubMed  CAS  Google Scholar 

  8. Belchetz P.E., Weldon S.F., Davis J.C., Diver M.J., Smith C.S., Harris F. Potential use of human pancreatic growth hormone-releasing factor 1–44 amide. Clin. Endocrinol. (Oxf.) 21: 201, 1984.

    Article  CAS  Google Scholar 

  9. Gelato M.C., Pescovitz O., Cassorla F., Loriaux D.L., Merriam G.R. Effects of a growth hormone releasing factor in man. J. Clin. Endocrinol. Metab. 57: 674, 1984.

    Article  Google Scholar 

  10. Rosenthal S.M., Schriock E.A., Kaplan S.L., Guillemin R., Grumbach M.H. Synthetic human pancreas growth hormone secretion in normal man. J. Clin. Endocrinol. Metab. 56: 677, 1983.

    Article  Google Scholar 

  11. Sassolas G., Chatelain P., Choen R., Biossel J.P., Laporte S., Galleyrand J., Claustrat B., Elmcharfi A., Chayvialle J.A., Cohen H., Ferry S., Underwood L. Effects of human pancreatic tumor growth hormone-releasing hormone (hp GRH 1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. J. Clin. Endocrinol. Metab. 59: 705, 1984.

    Article  PubMed  CAS  Google Scholar 

  12. Von Werder K., Müller O.A., Martl R., Losa M., Stalla G.K. Growth hormone releasing factor (hpGRF)-stimulation test in normal and acromegalic patients. J. Clin. Endocrinol. Metab. 7: 185, 1984.

    Google Scholar 

  13. Giusti M., Mazzocchi G., Sessarego P., Mignone D., Lomeo A., Monachesi M., Giordano G. Effects of GRF (1–40) and domperidone on GH secretion in normal man. Clin. Endocrinol. (Oxf.) 21: 339, 1984.

    Article  CAS  Google Scholar 

  14. Thorner M.O., Rivier J., Spiess J., Borges J.L., Vance M.L., Bloom S.R., Rogol A.D., Cronin M.J., Kaiser D.L., Evans W.S., Webster J.D., Macleod R.M., Vale W. Humans pancreatic growth hormone -releasing factor selectively stimulates growth- hormone secretion in man. Lancet 1: 24, 1983.

    Article  PubMed  CAS  Google Scholar 

  15. Grossman A., Savage M.O., Lytras N., Preece M.A., Sueiras-Diaz J., Coy D.H., Rees L.H., Besser G.M. Responses to analogues of growth hormone releasing hormone in normal subjects, and in growth-hormone deficienct children and young adults. Clin. Endocrinol. (Oxf.) 21: 321, 1984.

    Article  CAS  Google Scholar 

  16. Chiodini P.G., Liuzzi A., Dallabondanza D., Opizzi G., Verde G.G. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone 1–44 in acromegaly: A comparison with thyrotropin releasing hormone and bromocriptine. J. Clin. Endocrinol. Metab. 60: 48, 1985.

    Article  PubMed  CAS  Google Scholar 

  17. Losa M., Schopohl J., Stalla G.K., Müller O.A., Von Werder K. Growth hormone releasing factor test in acromegaly: comparison with other dynamic tests. Clin. Endocrinol. (Oxf.) 23: 99, 1985.

    Article  CAS  Google Scholar 

  18. Pieters G.F.F.M., Smais A.E.M., Hermus A.R.M.M., Smals A.G.H., Benraad T.H.J., Kloppenborg P.W.C. Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration. Clin. Endocrinol. (Oxf.) 21: 701, 1984.

    Article  CAS  Google Scholar 

  19. Shibasaki T., Shizume K., Masuda A., Nakashara N., Hizuka N., Miyakava M., Takano K., Demura H., Wakabayashi I., Liny N. Plasma growth hormone response to growth -hormone releasing factor in acromegalic patients. J. Clin. Endocrinol. Metab. 58: 215, 1984.

    Article  PubMed  CAS  Google Scholar 

  20. Wood S.M., Ch’ng J.L.C., Adams E.F., Webster J.D., Jopling J.F., Mashiter K., Bloom S.R. Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF1-44) in acromegaly and hypopituitarism. Br. Med. J. 286: 1687, 1983.

    Article  CAS  Google Scholar 

  21. Gelato M.C., Merriam G.R., Vance M.L., Goldman J.A., Webb C., Evans W.S., Rock J., Oldfield E.H., Molitch M.E., Rivier J., Vale W., Reichlin S., Frohman L.A., Loriaux D.L., Thorner M.O. Effects of growth hormone — releasing factor on growth hormone secretion in acromegaly. J. Clin. Endocrinol. Metab. 60: 251, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Giusti M., Sessarego P., Monachesi M., Lomeo A., Tarditi V., Mignone D., Del Monte P., Giordano G. Effetto del tono dopaminergic sulla secrezione di GH nel soggetto normale e acromegalico: dati preliminari. J. Endocrinol. Invest. 7(Suppl. 1): 7, 1984.

    Google Scholar 

  23. Arafah B.H., Brodkey J.S., Kaufman B., Velasco M., Manni A., Pearson O.H. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J. Clin. Endocrinol. Metab. 50: 578, 1980.

    Article  PubMed  CAS  Google Scholar 

  24. Schaison G., Couzinet B., Moatti N., Pertuset B. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery. Clin. Endocrinol. (Oxf.) 18: 541, 1983.

    Article  CAS  Google Scholar 

  25. Greenwood F.C., Landon J., Stamp J.C.B. The plasma sugar, free fatty acid, Cortisol, and growth hormone response to insulin. I. In control subjects. J. Clin. Invest. 45: 429, 1966.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  26. Giusti M., Mortara R., Bolognesi F., Mignone D., Giordano G. Sleep-wake behaviour and integrated values of LH, FSH, PRL, GH and TSH in Klinefelter’s syndrome. J. Endocrinol. Invest. 2: 385, 1979.

    Article  PubMed  CAS  Google Scholar 

  27. Daughaday W.H., Mariz I.K., Blethen S.L. Inhibition of access of bound somatomedin to membrane receptor and immunoglobulin sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J. Clin. Endocrinol. Metab. 51: 781, 1980.

    Article  PubMed  CAS  Google Scholar 

  28. Armitage P. Statistica medica. Metodi statistici per la ricerca in medicina. G. Feltrinelli, Milano, 1982, p. 215.

    Google Scholar 

  29. Malarkey W.B., Daughaday W.H. The influence of levo-dopa and adrenergic blockade on GH and PRL secretion in the MTW 15 tumour bearing rat. Endocrinology 91: 1314, 1972.

    Article  PubMed  CAS  Google Scholar 

  30. Arosio M., Ambrosi B., Guglielmino L., Faglia G. Human pancreatic growth hormone releasing factor (hpGRF 1-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion. J. Endocrinol. Invest. 8: 449, 1985.

    Article  PubMed  CAS  Google Scholar 

  31. Lamberts S.W., Verleun T., Oosterom R. The interrelationship between the effects of somatostatin and human pancreatic growth hormone — releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly. J. Clin. Endocrinol. Metab. 58: 250, 1984.

    Article  PubMed  CAS  Google Scholar 

  32. Mashiter K., Adams E.F. Secretion of growth hormone by normal and tumourous human pituitary somatotrophs in cell culture. Proceedings International Congress, Endocrinology’ 85, Torino, June 5–8, 1985, Abstract 5.

  33. Weeb C.B., Thominet J.L., Frohman L.A. Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro. J. Clin. Endocrinol. Metab. 56: 417, 1983.

    Article  Google Scholar 

  34. Thorner M.O., Frohman L.A., Leong D.A., Thominet J., Downs T., Hellmann P., Chitwood J., Vaughan J.M., Vale W., Besser G.M., Lytras N., Edwards C.R.W., Schaff M., Gelato M., Krieger D.T., Marcovitz S., Ituarte E., Boyd A.E., Malarkey W.B., Blackard W.B., Prioleau G., Melmed S., Charest N.J. Extrahypothalamic growth -hormone- releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J. Clin. Endocrinol. Metab. 59: 846, 1984.

    Article  PubMed  CAS  Google Scholar 

  35. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L. Somatomedin-C mediates growth hormone negative feed back by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1981.

    Article  PubMed  CAS  Google Scholar 

  36. Schulte H.M., Benker G., Windek R., Olbricht T., Reinwein D. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH-secreting pancreatic tumor: dynamics of multiple endocrine testing. J. Clin. Endocrinol. Metab. 61: 585, 1985.

    Article  PubMed  CAS  Google Scholar 

  37. Thorner M.O., Perryman R.L., Cronin M.J., Rogol A.D., Draznin M., Johanson A., Vale W., Horvath E., Kovacs K. Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone releasing factor. J. Clin. Invest. 70: 965, 1982.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  38. Wilson D.M., Ceda G.P., Bostwick D.G., Webber R.J., Minkoff J.R., Pont A., Hintz R.L., Bensch K.G., Kraemer F.B., Rosenfeld R.G., Hoffman A.R. Acromegaly and Zollinger — Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone — releasing factor. J. Clin. Endocrinol. Metab. 59: 1002, 1984.

    Article  PubMed  CAS  Google Scholar 

  39. Ishibashi M., Yamaji T. Effect of thyrotropin-releasing hormone and bromocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly. J. Clin. Endocrinol. Metab. 47: 1251, 1978.

    Article  PubMed  CAS  Google Scholar 

  40. Denef C., Baes M., Schramme C. Paracrine interactions in the anterior pituitary: role in the regulation of prolactin and growth hormone secretion. In: Ganong W.F., Martini L. (Eds.), Frontiers in neuroendocrinology. Raven Press, New York, 1986, vol. 9, p. 115.

    Google Scholar 

  41. Losa M., Müller O.A., Schopohl J., Stalla G.K., Von Werder K. Growth hormone releasing factor stimulates prolactin secretion in acromegaly. Neuroendocrinol. Lett. 7: 99, 1985.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto Scientifico di Medicina Interna, Cattedra di Endocrinologia, University of Genova, Viale Benedetto XV 6, 16132, Genova, Italy

    Massimo Giusti M.D., A. Lomeo, M. Monachesi, G. Mazzocchi, R. Attanasio, P. Sessarego, D. Mignone, P. Del Monte & G. Giordano

Authors
  1. Massimo Giusti M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lomeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Monachesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Mazzocchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Attanasio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Sessarego
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Mignone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Del Monte
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giusti, M., Lomeo, A., Monachesi, M. et al. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. J Endocrinol Invest 10, 143–151 (1987). https://doi.org/10.1007/BF03347179

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347179

Key-words

Search

Navigation